Similar to curcumin (Cur), CA-1 has the characteristics of inducing tumor death through chemotherapy to enhance tumor immunogenicity, and effectively recruit CD4+T helper cells (Th) and CD8+ cytotoxic T lymphocytes (CTL) for the enhancement of anti-tumor immune responses. This evidence concerns the gene CD4 and neoplasm.